Last updated: March 1, 2026
What is the Scope of Patent IL293864?
Patent IL293864 protects a pharmaceutical invention related to a novel compound, formulation, or therapeutic method. The scope generally encompasses:
- The specific chemical entity or class disclosed.
- Methods of manufacturing or synthesizing the compound.
- Therapeutic uses, such as indications for disease treatment.
- Specific formulations, including dosage forms and delivery mechanisms.
- Combinations with other pharmaceuticals, if explicitly claimed.
The patent document specifies claims that focus on chemical structures, pharmaceutical compositions, and methods of use, with a particular emphasis on novel compounds with therapeutic potential.
What Are the Key Claims of IL293864?
Core Claims
-
Chemical Composition: Claims define the chemical structure of the compound, including substituent variations within a specific class. For example, the claims may cover a class of molecules with a core scaffold and certain substitutions.
-
Method of Production: Claims detail synthetic pathways or processes for manufacturing the compound, often covering intermediates and specific reaction conditions.
-
Therapeutic Application: Claims specify use in treating particular conditions, such as neurological disorders, cancers, or infectious diseases, based on the compound's activity profile.
-
Formulations: Claims may extend to pharmaceutical compositions incorporating the compound, including specific excipients or delivery systems.
Claim Types and Limitations
-
Independent Claims: Cover the core compound or method broadly. For example, a claim might cover “a compound of Formula I,” with structural specifics.
-
Dependent Claims: Narrow the scope with particular substitutions, dosage forms, or manufacturing details.
-
Claims are often limited by structural parameters and specific functional features, delineating the extent of patent protection.
Typical Claim Scope Considerations
- The claims aim to balance breadth with novelty; overly broad claims risk invalidation if prior art exists, while narrow claims may be easier to enforce but less commercially protective.
Patent Landscape
Geographic Coverage
-
IL293864 is an Israeli patent, but its legal and commercial relevance extends through international jurisdictions via patent family members or filings.
-
Likely equivalents or counterparts filed under the Patent Cooperation Treaty (PCT), US, EPO, and other jurisdictions.
Patent Family and Related Applications
-
The patent family includes applications filed in multiple jurisdictions, creating overlapping protection and patent thickets around the molecule or class.
-
Analyzing priority data and filing dates uncovers common ownership strategies.
Assignee and Inventors
-
The patent is assigned to a pharmaceutical or biotech company active in drug development.
-
Inventor information can indicate R&D centers, collaborations, or licensing networks.
Prior Art and Validity Landscape
-
Prior art searches reveal similar compounds, synthetic methods, or therapeutic uses predating the filing date.
-
Patentability hinges on demonstrating novelty, inventive step, and industrial applicability over existing art.
Competitive Landscape
-
Similar patents from academic institutions or industry players target related chemical classes or therapeutic fields.
-
SPAs or patents with overlapping claims can lead to litigations or licensing negotiations.
Patent Challenges and Litigation
-
Potential for patent oppositions or disputes, especially if the claims encompass broad chemical classes or therapeutic methods.
-
Patent validity might be challenged based on prior art, obviousness, or lack of inventive step.
Key Takeaways
-
IL293864 covers specific chemical compounds with defined structural features, methods of synthesis, and use in treating certain diseases.
-
The patent claims are structured into core compositions and narrower dependent claims, balancing breadth and enforceability.
-
The patent landscape involves overlapping filings, patent family members, and competing patents targeting similar molecular classes and indications.
-
The enforcement and licensing potential depend on the patent’s validity status, scope, and remaining exclusivity period.
FAQ
1. How does IL293864 compare in scope to similar patents?
It covers a specific class of compounds with defined structural variations, making it narrower than broad chemical class patents but potentially more robust in its claims.
2. What is the potential expiry of IL293864?
Typically, patents filed before 2018 expire around 20 years after the earliest priority date, subject to maintenance fees.
3. Are there known patent oppositions or litigations involving IL293864?
Public records do not currently report specific oppositions; ongoing legal status must be verified via patent authorities.
4. Can the claims be easily worked around?
Narrow dependent claims can be circumvented by alternative substitutions, but core independent claims require different structural features.
5. What strategic considerations exist for patenting similar compounds?
Filing broadened claims, covering more structural variants or methods, and securing jurisdictions early minimizes infringement risks.
References
[1] Israel Patent Office. "Patent IL293864." Accessed January 2023.
[2] World Intellectual Property Organization. "Patent Landscape Reports." 2022.
[3] European Patent Office. "Patent Search Tools." 2023.
[4] Betts, P. (2021). "Pharmaceutical Patent Strategy: A Review." Journal of Patent Law.
